Experts give their top picks and hot tips on data being presented at the upcoming European Congress of Rheumatology taking place on June 12-15 in Vienna, Austria.
In its new evidence-based clinical practice guideline, the Endocrine Society recommends against routine 25(OH)D testing in the absence of indications and limiting vitamin D supplementation.
Will the threats associated with artificial intelligence be as bad as some fear? Or will AI be relatively benign? Could the answer be somewhere in between?
Five-year follow-up data from the landmark CROWN trial shows significant progression-free survival in ALK+ NCSLC, but some experts question the use of crizotinib as the comparator drug.